Compare INVA & DXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INVA | DXC |
|---|---|---|
| Founded | 1996 | 1959 |
| Country | United States | United States |
| Employees | N/A | 115000 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2000 | 2016 |
| Metric | INVA | DXC |
|---|---|---|
| Price | $21.27 | $11.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | ★ $32.80 | $15.00 |
| AVG Volume (30 Days) | 608.5K | ★ 2.3M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 816.67 | N/A |
| EPS | ★ 1.25 | 0.73 |
| Revenue | $217,217,000.00 | ★ $12,644,000,000.00 |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $12.65 | N/A |
| P/E Ratio | $17.00 | ★ $16.06 |
| Revenue Growth | ★ 62.63 | N/A |
| 52 Week Low | $16.52 | $7.90 |
| 52 Week High | $25.15 | $15.68 |
| Indicator | INVA | DXC |
|---|---|---|
| Relative Strength Index (RSI) | 51.23 | 63.71 |
| Support Level | $20.32 | $11.36 |
| Resistance Level | $21.91 | $12.04 |
| Average True Range (ATR) | 0.33 | 0.42 |
| MACD | 0.06 | 0.06 |
| Stochastic Oscillator | 56.09 | 85.31 |
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
DXC Technology Co is a vendor-independent IT services provider. The company's operating segment includes Global Business Services (GBS) and Global Infrastructure Services (GIS). It generates maximum revenue from the GIS segment. GIS offerings include Cloud and Security; IT Outsourcing and Modern Workplace. Geographically, it derives a majority of revenue from the Other Europe region.